The PhD Programme in "Artificial Intelligence in Medicine and Innovation in Clinical and Methodological Research" is an interdisciplinary program aimed at promoting and developing research on technological innovation, especially artificial intelligence, in healthcare.
The PhD Programme promotes and initiates research programs on the potential applications of new technologies in biomedicine, bioengineering, bioinformatics, and neuroscience, highlighting their innovative and sometimes revolutionary nature while also highlighting their primary philosophical and legal implications.
Thanks to this interdisciplinary approach, the program offers the holistic perspective necessary to address research programs driven by artificial intelligence in medicine and surgery, regenerative medicine and cell therapy, as well as in the planning and conduct of experimental clinical trials.
The PhD Programme is organized into four curricula:
Artificial Intelligence in Medicine
This curriculum, aimed primarily at physicians, biologists, physicists, engineers, biostatisticians, computer scientists, and healthcare economists, but also at lawyers and philosophers, offers primary career opportunities in the development of algorithms and artificial intelligence systems applied to medical and surgical sciences, but also offers interesting and growing opportunities in academic research, high-level consulting, and corporate management.
Regenerative Medicine
This curriculum is aimed primarily (without excluding other disciplinary fields, starting with ethics and law) at physicians, biologists, physicists, and engineers. It offers priority career opportunities in research (both academic and corporate) on the biological mechanisms of tissue degeneration and regeneration, in the applications of cell and gene therapy, in the production of biomaterials and bio-nanotechnologies applied to regenerative medicine.
Innovation in Clinical Research and Methodology
This curriculum, aimed primarily at physicians, biologists, physicists, engineers, biostatisticians, computer scientists, and health economists, but also including ethicists, lawyers, and philosophers, offers priority career opportunities in the development of epidemiological studies, new molecularly targeted drugs, new personalized therapeutic strategies, telemedicine programs, and the management of patients with chronic or chronically ill conditions.
Artificial Intelligence, Philosophy, Neuroscience
This curriculum, aimed primarily at philosophers, neuroscientists, neurobiologists, neurorobotics specialists, engineers, computer scientists, ethicists, and lawyers, but not excluding all other disciplines, offers primary career opportunities in research (academic and otherwise) in philosophy, neuroscience/neurorobotics, and ethics/legal fields; in public and private healthcare consulting and management, both nationally and internationally; in companies and businesses developing brain devices (electrodes, microchips, etc.); and in national and international ethics committees.